Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus

Current Opinion in Oncology

Volumn 14, Issue 5, 2002, Pages 543-545

  Carraway, Hetty ^a   Ambinder, Richard F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GAMMOPATHY; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE MYELOMA; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; SHORT SURVEY;

HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; LYMPHOMA, B-CELL; PARAPROTEINEMIAS;

EID: 0036738250     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200209000-00012     Document Type: Short Survey

References (24)

1. Fiorino AS, Atac B: Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia 1997, 11:2150-2156.
2. Konrad RJ, Kricka LJ, Goodman DB, et al.: Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med 1993, 328:1817-1819.
3. Lefrere JJ, Debbia M, Lambin P: Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol 1993, 84:151-155.
4. Ng VL, Chen KH, Hwang KM, et al.: The clinical significance of human immunodeficiency virus type 1-associated paraproteins. Blood 1989, 74:2471-2475.
5. Cauda R, Lucia MB, Marasca G, et al.: Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy. Eur J Haematol 1999, 63:134-135.
6. Righetti E, Ballon G, Ometto L, et al. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. AIDS 2002, 16:63-73.
7. Cote TR, Manns A, Hardy CR, et al.: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996, 88:675-679.
8. Grulich AE, Li Y, McDonald A, Correll PK, et al.: Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002, 16:1155-1161.
9. Frisch M, Biggar RJ, Engels EA, et al.: Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001, 285:1736-1745.
10. Franceschi S, Dal Maso L, Arniani S, et al.: Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 1998, 78:966-970.
11. Heuberger L, Costello RT, Petit N, et al.: First case of plasma-cell leukemia co-existing with human immunodeficiency virus infection. Leukemia 1998, 12:103-104.
12. Kumar S, Kumar D, Schnadig VJ, et al.: Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol 1994, 102:633-639.
13. Nogues X, Supervia A, Knobel H, et al.: Multiple myeloma and AIDS. Am J Hematol 1996, 53:210-211.
14. Dunphy CH, Galambos C, Polski JM, et al.: Extranodal posttransplant plasmacytic hyperplasia with subsequent posttransplant plasmacytic malignancy: six-year interval case report and review of the literature. Arch Pathol Lab Med 2002, 126:351-356.
15. Larratt LM, Hamilton M, Coupland R, et al.: Recurrent Epstein-Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma. Transpl Infect Dis 2001, 3:119-123.
16. Pulik M, Genet P, Jary L, et al.: Acute myeloid leukemias, multiple myelomas, and chronic leukemias in the setting of HIV infection. AIDS Patient Care STDS 1998, 12:913-919.
17. Siebert JD, Ambinder RF, Napoli VM, et al.: Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus. Hum Pathol 1995, 26:1191-1195.
18. Glaser SL, Lin RJ, Stewart SL, et al.: Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997, 70:375-382.
19. Rettig MB, Ma HJ, Vescio RA, et al.: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients [see comments]. Science 1997, 276:1851-1854.
20. Chauhan D, Bharti A, Raje N, et al.: Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells. Blood 1999, 93:1482-1486.
21. Brousset P, Theriault C, Roda D, et al.: Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow biopsies of patients with Waldenström's macroglobulinaemia. Br J Haematol 1998, 102:795-797.
22. Matsushima AY, Strauchen JA, Lee G, et al.: Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol 1999, 23:1393-1400.
23. Brander C, Raje N, O'Connor PG, et al.: Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma. Blood 2002, 100:698-700.
24. Tarte K, Chang Y, Klein B: Kaposi's sarcoma-associated herpesvirus and multiple myeloma: lack of criteria for causality. Blood 1999, 93:3159-3163.